Pages that link to "Q40225720"

The following pages link to Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance (Q40225720):

Displayed 50 items.

• Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia (Q24310753) ‎ (← links)
• Chemical genomics identifies small-molecule MCL1 repressors and BCL-xL as a predictor of MCL1 dependency (Q24315549) ‎ (← links)
• miR-128b is a potent glucocorticoid sensitizer in MLL-AF4 acute lymphocytic leukemia cells and exerts cooperative effects with miR-221 (Q24643476) ‎ (← links)
• Regulation of Bim in Health and Disease (Q26781203) ‎ (← links)
• Arylamine N-acetyltransferase 1: a novel drug target in cancer development (Q26829025) ‎ (← links)
• Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignancies (Q26829652) ‎ (← links)
• The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics (Q27010154) ‎ (← links)
• Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (Q27025242) ‎ (← links)
• Systems biology approaches for advancing the discovery of effective drug combinations (Q27702922) ‎ (← links)
• Cell biology. Metabolic control of cell death (Q28397089) ‎ (← links)
• In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile (Q28472573) ‎ (← links)
• Utilization of genomic signatures to identify phenotype-specific drugs (Q28476014) ‎ (← links)
• Phenocopy--a strategy to qualify chemical compounds during hit-to-lead and/or lead optimization (Q28476479) ‎ (← links)
• Expression-based in silico screening of candidate therapeutic compounds for lung adenocarcinoma (Q28476794) ‎ (← links)
• Gene expression-based chemical genomics identifies potential therapeutic drugs in hepatocellular carcinoma (Q28477833) ‎ (← links)
• The Connectivity Map: a new tool for biomedical research (Q28530408) ‎ (← links)
• Multi-agent chemotherapy overcomes glucocorticoid resistance conferred by a BIM deletion polymorphism in pediatric acute lymphoblastic leukemia (Q28541556) ‎ (← links)
• MEK Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy (Q28552218) ‎ (← links)
• IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study (Q28555124) ‎ (← links)
• A miRNA-driven inference model to construct potential drug-disease associations for drug repositioning (Q28652746) ‎ (← links)
• Kinetic cell-based morphological screening: prediction of mechanism of compound action and off-target effects (Q28748600) ‎ (← links)
• Apoptosis inhibition by Bcl-2 gives way to autophagy in glucocorticoid-treated lymphocytes (Q30538797) ‎ (← links)
• Transcriptional data: a new gateway to drug repositioning? (Q30557854) ‎ (← links)
• Database of Gene Co-Regulation (dGCR): A Web Tool for Analysing Patterns of Gene Co-regulation across Publicly Available Expression Data (Q30886450) ‎ (← links)
• Identifying kinase dependency in cancer cells by integrating high-throughput drug screening and kinase inhibition data (Q30982375) ‎ (← links)
• Accessing and integrating data and knowledge for biomedical research. (Q31165447) ‎ (← links)
• Gene expression patterns within cell lines are predictive of chemosensitivity (Q33318982) ‎ (← links)
• Genomic-based high throughput screening identifies small molecules that differentially inhibit the antiviral and immunomodulatory effects of IFN-alpha (Q33334070) ‎ (← links)
• Gene expression module-based chemical function similarity search. (Q33374699) ‎ (← links)
• Combination chemical genetics (Q33378070) ‎ (← links)
• Cardiac glycosides induce cell death in human cells by inhibiting general protein synthesis. (Q33519074) ‎ (← links)
• Indirect two-sided relative ranking: a robust similarity measure for gene expression data (Q33541725) ‎ (← links)
• Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). (Q33645760) ‎ (← links)
• Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance (Q33755338) ‎ (← links)
• LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures (Q33860855) ‎ (← links)
• Estrogen coordinates translation and transcription, revealing a role for NRSF in human breast cancer cells (Q33874316) ‎ (← links)
• Mcl-1 ubiquitination: unique regulation of an essential survival protein (Q33883844) ‎ (← links)
• Gene expression associations with the growth inhibitory effects of small molecules on live cells: specificity of effects and uniformity of mechanisms (Q34007417) ‎ (← links)
• Activation-induced cytidine deaminase (AID)-associated multigene signature to assess impact of AID in etiology of diseases with inflammatory component (Q34044904) ‎ (← links)
• Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia. (Q34071295) ‎ (← links)
• Bioinformatics-driven discovery of rational combination for overcoming EGFR-mutant lung cancer resistance to EGFR therapy. (Q34103108) ‎ (← links)
• A searchable cross-platform gene expression database reveals connections between drug treatments and disease (Q34123013) ‎ (← links)
• Downstream gene activation of the receptor ALX by the agonist annexin A1. (Q34137344) ‎ (← links)
• Translation initiation factor eIF4F modifies the dexamethasone response in multiple myeloma (Q34218069) ‎ (← links)
• Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. (Q34260622) ‎ (← links)
• Combining ZHENG Theory and High-Throughput Expression Data to Predict New Effects of Chinese Herbal Formulae (Q34292354) ‎ (← links)
• A genomic signature approach to rescue ΔF508-cystic fibrosis transmembrane conductance regulator biosynthesis and function (Q34305593) ‎ (← links)
• Rapamycin sensitizes T-ALL cells to dexamethasone-induced apoptosis. (Q34387833) ‎ (← links)
• Stage 2 combination testing of rapamycin with cytotoxic agents by the Pediatric Preclinical Testing Program (Q34414736) ‎ (← links)
• A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia (Q34448969) ‎ (← links)